Price $2.30 |
Market Cap
250.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.22
|
P/S
62.73
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-71.9K
|
FCF
-0.9
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-36.30%
|
ROI
-
|
|
ROA
-32.80%
|
EPS Growth
6.10%
|
Current Ratio
10.1
|
Debt/Equity
1.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Accelerate Diagnostics Inc (AXDX) | $0.76 | - | - | 124.8M | Strong Buy |
| Acorda Therapeutics Inc (ACOR) | $0.57 | - | - | 18.9M | Strong Buy |
| Actinium Pharmaceuticals Inc (ATNM) | $10.28 | - | - | 274.5M | Strong Buy |
| Agile Therapeutics Inc (AGRX) | $0.19 | - | - | 54.1M | Strong Buy |
| AIM ImmunoTech Inc (AIM) | $0.40 | - | - | 26.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
